The stock of OrthoPediatrics Corp. (NASDAQ:KIDS) has been Initiated to Buy by Needham in its latest research note that was published on June 19. KIDS was given a price target of $53, with other Wall Street analysts also giving their reports regarding the stock. JMP Securities, analysts launched coverage of KIDS stock with a Mkt Outperform rating, according to their flash note to investors on February 20. Analysts at Piper Jaffray are sticking to their Overweight recommendation. However, on July 05, they lifted target price for these shares to $30 from $24.Analysts at Piper Jaffray, made their first call for the stock with a Overweight rating, according to a research note that dated back to July 05.
OrthoPediatrics’s stock is covered by 7 analysts, with 3 of them rating the stock as Buy. It has been deemed to have strong buy by 3 of the analysts, 1 of them have rated it as a Hold while none of them rated it as sell. The situation was different a month ago when the stock was rated as a Buy by only 3 analysts. 2 of them rated it as strong buy with 1 of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a sell. The above data shows that KIDS has an average analyst rating of 1.71.
OrthoPediatrics Corp., which has current market capitalization of above $450 Million, published its last quarter earnings on June 30, 2019. The company was able to amass $18.2 million in revenue. This figure is $0.23 million more than what analysts had expected which was $18.43 million. During the first quarter of the year, OrthoPediatrics also recorded $-0.17 earnings per share (EPS) which is $0.09 above the $-0.08 estimated by Thomson Reuter’s analyst, leading to a surprise factor of -106.56%.
KIDS surged by $0.80 during the normal trading session on Tuesday and reaching a high of $32.15 during the day while it closed the day at $30.28. The OrthoPediatrics stock had a low trading volume of 0.16 million shares on that day, which is low compared to the average daily volume of 84.13M shares. KIDS has also lost 4.36% of its value over the past 7 days. However, the stock has declined by 26.18% in the 3 months of the year. Over the past six months meanwhile, it has lost 14.80% while it has lost 13.19% year-on date. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -32.26% from its 3 months high price. However, taking another look at KIDS will indicate that it is trading +5.18% away from its 90-day low. Looking at the bigger picture, the OrthoPediatrics Corp. stock has dropped by -36.68% from its 52-week high while it has surged by +20.59% from its 52-week low price.
OrthoPediatrics has around 53 Billion cash on their books at the moment. This figure will have to be compared and looked into, with their current liabilities standing at $11 Billion. The OrthoPediatrics stock is bringing in revenue of over 12 months, which is roughly 15 Billion. Despite all that, OrthoPediatrics Corp. is seeing things progressing very much as their y-o-y quarterly revenue surged by 21.18%.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 9.37%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 15.35%. Over the past 20 days, OrthoPediatrics’s Stochastic %K stood at 20.42% while its Stochastic %D was revealed to be 22.19%.